echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > K Huijian has developed AI pathology robots to enter the market for autism and language development disorders in children.

    K Huijian has developed AI pathology robots to enter the market for autism and language development disorders in children.

    • Last Update: 2020-09-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: In China, the incidence of language disorders in children is about 2% to 3%.
    research and development of AI pathology robots, into the children's autism and language development disorders market in China, the incidence of language disorders in children is about 2% to 3%.
    1943, Leo Canner, an expert at Johns Hopkins University in the United States, first proposed the concept of autism.
    autism is a developmental disorder, medically lying about autism spectrum disorder, characterized by social disorders, communication disorders, and imaginative disorders.
    , the prevalence of autism has increased significantly in all countries of the world, with a incidence rate of 1% to 1.5%.
    March 26, 2020 - The U.S. Centers for Disease Control and Prevention releases the latest prevalence of autism spectrum disorder in the United States: 1 in 54 children is diagnosed with autism before age 8, an increase of nearly 10 percent over the previous estimate.
    has a huge impact on children's language development.
    children with autism have slow voice development compared to normal children.
    language disorders and other issues will make autistic children's interests become narrow, behavior become stereotyped repetition, personality become out of group, and more seriously, autism will make the patient's neurological function stagnation, seriously affecting the patient's normal life and physical development.
    , the incidence of language disorders in children is about 2% to 3%.
    11 per cent of children, such as stututus, were included in the statistics.
    or parents find that the child's illness is usually during their school-age period, while the child's golden age to gain language skills is 0-6 years old, and the child's language problems can be seriously harmful if they intervene later.
    children with disabilities have poor prognostication and are often unable to live, study and work independently in adult life, which can be a heavy burden on families and society, " said one expert.
    " Currently, there are no clinically targeted drugs to treat autism.
    However, a growing number of studies in recent years have found that early screening, early detection, and early behavioral intervention can significantly improve poor prognostication in children with autism, and that the earlier the age, the earlier the intervention, the more effective it is.
    , autism and children with language disorders have difficult problems such as late detection, difficult diagnosis, difficult identification and difficulty in recovery.
    to fill this gap in the market, Ko Huijian developed AI pathology series of robots. Zhu Lingyan, chairman of
    , said: "AI pathology series robots aim at the blank market for pathological voice analysis and intervention, using a combination of pathological voice intelligent neural network system, pathological voice big data and other technologies for early screening, clinical diagnosis and rehabilitation training of autism, speech disorders, speech retardation and other diseases."
    " Focusing on the pathological speech analysis and intervention market, Mr. Ko is a high-tech company that develops, produces and sells innovative AI series pathological robots to help children with autism and language-related developmental disabilities stay out of disease and grow up healthy and happy.
    Recently, In the final of the "2020 'Creative Guangdong' Biopharmaceutical Small and Medium Enterprise Innovation and Entrepreneurship Competition" hosted by Guangdong Medical Valley, Mr. Ko won the third prize of the enterprise group by virtue of its technological advantages and project highlights, and was supported by a number of awards, including the Guangdong Medical Valley Nansha Industrial Park New Settlement Award, Rent Subsidy, Innovation Voucher Award, etc.
    , Ko Huijian has been stationed in Nansha Industrial Park, Guangdong Medical Valley.
    Relieing on original core technology, research and development of AI pathology robots, Zhu Lingjianyuan chairman Zhu Lingyan told Arterial Network: "China's autism intervention industry started late, at present, there are fewer doctors with the ability to diagnose autism, autism rehabilitation teachers can only cover 3-5% of the autistic population."
    , some rehabilitation institutions do not have complete access to medical interventions and lack complete and effective safety and effectiveness assessments.
    therefore, the market urgently needs sophisticated, professional screening, diagnosis, and rehabilitation equipment for autism and language-related developmental disorders.
    " the pathology robot developed by K huijianyuan is popular with the target market with its excellent performance, excellent sperm effectiveness, high accuracy of screening and pathological diagnosis.
    : "In 2019 and a half years alone, SALES of AI pathology series robots exceeded 10 million yuan, " said Zhu Lingyan, a professor at the University of Beijing.
    may 2020, product sales exceeded 12 million yuan, and it is expected to achieve a total revenue of 30 million yuan for the full year.
    " What are the basic principles of AI pathology robots? It is understood that the AI pathology series robot developed by Ko Huijianyuan uses artificial intelligence face recognition technology, eyeliner data analysis technology, pathological speech digital analysis technology, autism and language-related disorders screening system to screen and identify diseases such as language stunting, child voice dysfunction, autism, and overall speech movement retardation.
    Face Intelligent Recognition Technology combines the database with the face deep learning model to capture the dynamic face information of the children under the situation paradigm, analyze the real-time model, and identify whether there is a possible weight of autism.
    eye movement device screens and diagnoses autism in children with face intelligence technology through line-of-sight trajectory and visual attention concentration.
    pathological speech digital analysis technology, by extracting the relevant acoustic characteristic parameters, calculated the comprehensive acoustic parameters, using a two-module weight comprehensive method, screening out the children's sound barrier.
    screening system for autism and language-related disorders is divided into four modules: language stunting module, voice dysfunction module, autism module, and motor development retardation module.
    language stunting module is the foundation and core of screening, and the module is connected to the other three modules by algorithmic technology.
    user first enters the language stunting module and selectively enters the other three modules according to the calculation.
    , the Autism and Language-Related Disorders Screening System combines face intelligence recognition technology, eyeliner data analysis technology, and pathological voice digital analysis technology to intelligently screen users.
    : "The AI screening system has significant advantages over traditional autism or language retardation scales," said Zhu Lingyan, a professor at the University of New China.
    first, the system can achieve a comprehensive multi-dimensional picture of autism characteristics.
    , intelligently recognizes children's facial emotions, making it easy to identify children's autism.
    third, through eyeliner technology feedback on children's eye contact, stimulate children's desire to communicate.
    fourth place, more local than the overseas assessment forms currently in use.
    fifth, can use precision molding technology to prepare AI robots, low processing costs, suitable for large-scale production.
    " So far, AI pathology series robots have been piloted, mass production.
    based on the results of the technical test platform and clinical testing in more than 20 hospitals: children with autism and language development disorder AI pathological robot pathology speech recognition rate reached 95%, screening system confidence efficiency reached 97%.
    structure difference between different batches of diagnostics and screenings is less than 10-3.
    is also a leading international achievement.
    It is worth mentioning that AI pathology series robot second- and third-generation products in more than 20 hospitals for clinical trials, the effect is good, has been affiliated with Jinan University First Hospital, Zhongshan One Doctor, Wuhan One Doctor, Jingzhou Central Hospital and other three hospitals recognized.
    Four categories of products, dozens of application scenarios, assisted diagnosis screening At present, Ko Huijian has laid out children's autism and language development disorder screening robot, diagnostic robot, rehabilitation equipment empowerment, big data four categories of products, product application scenarios up to dozens of, for hospitals, special schools, rehabilitation institutions, nursing homes and other institutions for autism and language-related developmental disorders screening, not only high diagnostic rate, system stability, but also a wide audience.
    AI pathology series robots can enable children, the elderly and other groups to do rehabilitation at home, reduce the burden of government, hospitals and society, improve the health of the whole population, improve the well-being of special groups.
    addition, the combination of intelligent algorithms and pathological big data makes screening more objective, accurate, fast, and meets the needs of primary autism screening, providing the possibility for autism screening techniques to sink.
    ai pathology series robots will promote primary and graded diagnosis and treatment at the grass-roots level, and improve the utilization rate of medical resources.
    : "Intelligent medical field is an important direction of scientific development, but also the inevitable development of science."
    The AI pathology series robot developed by Ko Huijianyuan can promote the progress of domestic neurology, neuroregeneration, speech disorders, intra-brain nerves and other technologies, enhance China's scientific research level and industrial strength in speech construction, pathological speech recognition, improve the development ability of relevant big data voice library and artificial intelligence products, and bring them into line with the world's advanced technology and development trends.
    " AII pathology series robot research and development and production will also promote the coordinated development of the relevant industrial chain, help traditional industries through the use of intelligent modules to achieve industrial upgrading, promote national and local economic development, increase tax revenue, increase employment.
    process, Ko Huijianyuan will also develop into an influential national brand enterprise with Chinese characteristics.
    to ensure the uniqueness of the product, Ko Huijian has paid great attention to the protection of technological intellectual property rights since the start of the project.
    so far, Keyi Jianyuan around the project core technology, a total of more than 70 domestic and foreign invention patents, the core technology to form layer protection.
    present, Ko Huijian has mastered DNN's automatic identification technology for four classified diseases, and is the only company in China that has mastered multimedia feedback control system based on physiological signals and brainwave signals.
    At the same time, Ko Huijianyuan was the first to fully grasp the role and mechanism of non-visual optical information conduction system in regulating emotional and cognitive functions, first of all, using large-scale high-dimensional data aggregation algorithm based on non-explicit privacy protection to establish pathology libraries and large data centers... Zhu Lingyan told Arterial.com: "Ko Huijian has so many technological innovations, because the core team's innovation ability is strong."
    we have assembled Ph.D.s and Master's degrees in clinical medicine, artificial intelligence, statistics, sociology, computer technology, and marketing, and have been developing this project since 2016.
    , the core team consists of Ph.D.s and master's degrees, all with more than 20 years of experience, is a senior expert in the industry.
    , team members have published thousands of papers in top international journals.
    " On the future, Mr. Ko will work with universities or research institutions at home and abroad to jointly develop artificial intelligence-based screening and diagnostic equipment to keep technology advanced in the world, so as to seize foreign markets.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.